Subscribe

The American Academy of Pediatrics (AAP) 1998 Recommendations for Palivizumab and RSV-IGIV to Prevent RSV Infection

Specialty:

Infectious Diseases
Clinical Pharmacology & Toxicology
Pulmonology & Critical Care
Nephrology, Urology, Obstetrics & Gynecology, Pedatrics, Genetics

Objective:

ICD-10:

Description:

The American Academy of Pediatrics (AAP) issued recommendations for the use of palivizumab and RSV IV immune globulin (RSV-IVIG) for prophylaxis to prevent severe lower respiratory tract infections caused by respiratory syncytial virus (RSV). Both agents can significantly reduce hospitalizations in high risk infants and young children.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone